Scientific Poster

Fluorescein Angiography in ROP A New Dimension! by Susana Teixeira, Ana Sofia Lopes, Graça Pires, Filomena Silva, Isabel Prieto, Portugal

Susana Teixeira, Ana Sofia Lopes, Graça Pires, Filomena Silva, Isabel Prieto, Portugal

Retinopathy of prematurity is one of the leading causes of childhood blindness around the world. The physiopathology, clinic and treatment of this disease are still under sparkling investigation. Fluorescein angiography of premature eye help us to have a better insight of the disease and guide us in its treatment. We present 6 cases of ROP where wide field angiography performed with RetCam was of great help in the more accurate characterization of the disease and in therapeuti cal decision. One case is a type 1 ROP (stage3-zone2) where the identification of ischemic areas guided the lasertherapy. Another case is a relapsing disease after intravitreal bevacizumab with double proliferation: at the first proliferation site and at the advancing edge. In this case angiography give us a more precise characterization of the disease. Two other cases illustrate the vascular findings in peripheral retinal vessels 1 year after intravitreal bevacizumab injection. Another case was performed in infants who had vitrectomy for stage IV ROP. Finely the authors present a case of an atypical form of ROP with severe fibrovascular proliferation nasal to the optic disc that rises difficulties in the diagnosis and consequently its therapy. Fluorescein angiography is not an absolute need in the diagnosis and treatment of ROP but is a wonderful tool that allow us to have new perspectives about vascular diseases of the child eye.

Contact Details:

Susana Teixeira
H Fernando Fonseca
Lisbon
Portugal
Cell Phone : +351 917630432
Work Phone : +351214930182
Email : susanateixeira.oft@gmail.com